AMERICAN ORIENTAL BIOENGINEERING INC
CIK 0001090514
Revenue (TTM)
$88.66M
−31.8% YoY
Q3 Jan 2014
Net Income (TTM)
−$36.01M
+11.5% YoY
Q3 Jan 2014
EPS Diluted (TTM)
−$1.17
+13.3% YoY
Q3 Jan 2014
Gross Margin
21.5%
Q3 Jan 2014
Operating Margin
-76.1%
Q3 Jan 2014
Net Margin
-40.6%
Q3 Jan 2014
Free Cash Flow (TTM)
−$65.12M
Q3 Jan 2014
Cash
$3.23M
Q3 Jan 2014
Total Debt
$5.12M
Q3 Jan 2014
Shares Outstanding
36.57M sh
Q3 Jan 2014